News from alzecure pharma ab A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

17 Nov, 2020, 07:21 GMT AlzeCure publishes its interim report for January - September 2020

AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that its interim report for the period January - September 2020 is now available on the...


12 Nov, 2020, 11:30 GMT AlzeCure receives approval to start clinical Phase I trial with ACD856 in Alzheimer's disease

AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the...


11 Nov, 2020, 09:13 GMT Poster presentation with the Alzstatin platform now available on AlzeCure's website

AlzeCure Pharma AB (publ) (FN STO: ALZCUR) ("AlzeCure"), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases...


11 Nov, 2020, 09:13 GMT Poster presentation with ACD856 in Alzheimer's now available on AlzeCure's website

AlzeCure Pharma AB (publ) (FN STO: ALZCUR) ("AlzeCure"), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases...


13 Oct, 2020, 09:27 BST AlzeCure gets abstract on the NeuroRestore platform against Alzheimer's accepted for poster presentation at CTAD

AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the...


08 Oct, 2020, 09:19 BST AlzeCure gets abstract on the Alzstatin platform against Alzheimer's accepted for poster presentation at CTAD

AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the...


28 Sep, 2020, 09:18 BST AlzeCure Pharma provides a scientific update on Alzheimer's disease and the Alzstatin project platform

AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the...


25 Aug, 2020, 07:30 BST AlzeCure publishes its interim report for January - June 2020

AlzeCure Pharma AB (publ) (STO: ALZCUR) today announced that its interim report for the period January - June 2020 is now available on the company's...


04 Jun, 2020, 10:28 BST AlzeCure Announces Positive Data From Clinical Study with ACD856

AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the...


20 May, 2020, 18:12 BST Report From the Annual General Meeting of AlzeCure Pharma on 20 May 2020

Today, 20 May 2020, the annual general meeting was held in AlzeCure Pharma AB (publ). Below is a summary of the resolutions made. All resolutions...


14 May, 2020, 11:07 BST Doctoral Thesis in Alzheimer's Awarded Best Thesis 2019 at Sahlgrenska Academy

AlzeCure Pharma AB (publ) (FN STO: ALZCUR) and Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden, have had a multi-year research...


05 May, 2020, 07:24 BST AlzeCure Publishes its Interim Report for Q1 2020

AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that its interim report for the first quarter of 2020 is now available on the company's...


30 Apr, 2020, 07:26 BST A New Doctoral Thesis in Alzheimer's Presented Today by AlzeCure Pharma and Karolinska Institutet

AlzeCure Pharma AB (publ) (UN STO: ALZCUR) and Karolinska Intitutet have had a long-term collaboration in the CNS field, and their joint doctoral...


15 Apr, 2020, 07:16 BST AlzeCure Pharma Publishes its Annual Report for 2019

AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that its Annual Report for 2019 has been published. The Annual Report is attached as a PDF ...


02 Apr, 2020, 16:45 BST AlzeCure Pharma Today Presented Key Preclinical Data on its Novel Cognitive Enhancer at the AAT-AD/PD Conference

AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today had a late breaking presentation at the AAT-AD/PD conference (Advances in Alzheimer's and...


16 Mar, 2020, 07:20 GMT AlzeCure Pharma to Present Late Breaking Abstract at the AAT-AD/PD Conference (Advances in Alzheimer's and Parkinson's Therapies)

AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that it has received acceptance of a late breaking abstract presentation at the AAT- AD/PD ...


08 Jan, 2020, 09:17 GMT Martin Jönsson Appointed New CEO of AlzeCure Pharma

AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the...


07 Jan, 2020, 09:35 GMT AlzeCure Pharma Conducts Strategic Inlicensing of Clinical Phase Drug Candidate for Neuropathic Pain

AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the...


20 Dec, 2019, 11:54 GMT AlzeCure Initiates Clinical Trial With ACD856

AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the...


22 Aug, 2019, 08:12 BST AlzeCure Publishes its Interim Report for January - June 2019

AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that its interim report for the January - June 2019 is now available on the company's...


22 May, 2019, 16:43 BST Report from the Annual General Meeting of AlzeCure Pharma on 22 May 2019

Today, 22 May 2019, the annual general meeting was held in AlzeCure Pharma AB (publ). Below is a summary of the resolutions made. All resolutions...


03 May, 2019, 19:14 BST AlzeCure Changes Direction for its Drug Candidate ACD855 Within the NeuroRestore Platform

AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that they will redirect the drug candidate ACD855 within the research platform...


15 Apr, 2019, 16:54 BST AlzeCure Publishes its Annual Report for 2018

AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that its Annual Report for 2018 is now available on the company's website,...


25 Mar, 2019, 07:18 GMT AlzeCure to Present at International Scientific Conference

AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that it will have two presentations at AD/PD 2019, the 14th International Conference on...


20 Mar, 2019, 07:14 GMT AlzeCure Initiates New Drug Project Within Pain

AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that it has started a new preclinical drug project, TrkA-NAM, which is based on the...